SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

National Association For Continuing Education

Course Directors
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Deborah Paschal, CRNP
Philadelphia, PA

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Course Reviewer
Greg Mattingly, MD
Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
St. Louis, MO

: Making a Difference in ADHD: Screening and Treating for Primary Care
Activity/Course #:
: NCME343
: Free
Release/Start Date:
: Jan 05 2018
Expiration Date:
: Jan 04 2019
: Psychiatry
Target Audience:
: Primary Care Providers
: Monograph
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.25 pharmacology hour(s)
Hardware/Software Requirements:
Despite the lingering myth that attention deficit hyperactivity disorder (ADHD) is a condition of childhood, half or more of cases persist into adulthood. Because of its pervasive effects on cognition and behavior, ADHD greatly impacts the lives of adults by damaging relationships, limiting achievement, and increasing risk for accidents, substance abuse, and criminality. Early diagnosis and treatment of adults with ADHD is essential to limiting these consequences. Unfortunately, adults with ADHD are frequently undiagnosed and untreated.

Primary care clinicians play a central role in the recognition and management of ADHD in adults. In this monograph, we will review current evidence and guidelines describing the epidemiology, presentation, assessment, and management of ADHD in adults.

Learning objectives

After completing this program participants should be able to:

  1. Recognize the pervasive nature of ADHD symptoms throughout the day
  2. Describe the physical and psychologic morbidity and mortality associated with ADHD
  3. Use adult ADHD assessment and treatment tools to measure residual symptoms and optimize outcomes
  4. Implement pharmacologic treatment to optimize symptom control throughout the day

How to Obtain Your CME Certificate

  1. Register for the course at
  2. Complete the pre-test.
  3. View the content.
  4. Complete and submit the post-test and evaluation.
  5. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  6. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education(which includes 0.25 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosures are provided below.

In the past 12 months Dr. Mattingly has served as speaker for: Allergan, Lundbeck, Merk, Otsuka, Shire, Sunovion, Takeda, and Vanda; served as consultant for: Alkermes, Allergan, Forum, Lundbeck, Merk, Otsuka, Perdue, Rhodes, Shire, Sunovion, Takeda and Vanda; done Research for: Akilii, Alcobra, Alkermes, Allergan, Boehring, Forum, Janssen, Medgenics, NLS-1 Pharma AG, Reckitt Benckiser, Shire, Sunovion, Supernus and Takeda.

Gregg Sherman, MD, Co-Course Director, has no relationships to disclose.

Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by an independent medical educational grant from Shire.